MRPL37 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.563400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.456400E-01
Normal-vs-Stage2
4.882000E-01
Normal-vs-Stage3
9.499200E-01
Normal-vs-Stage4
3.151600E-01
Stage1-vs-Stage2
1.468790E-01
Stage1-vs-Stage3
7.700000E-01
Stage1-vs-Stage4
1.150590E-01
Stage2-vs-Stage3
3.816400E-01
Stage2-vs-Stage4
4.575000E-01
Stage3-vs-Stage4
3.210200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.854800E-01
Normal-vs-AfricanAmerican
4.172600E-01
Normal-vs-Asian
2.300200E-01
Caucasian-vs-AfricanAmerican
8.594000E-01
Caucasian-vs-Asian
4.066200E-01
AfricanAmerican-vs-Asian
6.300000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.774600E-01
Normal-vs-Female
5.390800E-01
Male-vs-Female
2.867800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.767600E-01
Normal-vs-Age(41-60Yrs)
3.750600E-01
Normal-vs-Age(61-80Yrs)
6.416600E-01
Normal-vs-Age(81-100Yrs)
5.181200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.931020E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.467800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.198800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.607900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.502800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.326400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.279800E-01
Normal-vs-Daily Drinker
4.695800E-01
Normal-vs-Weekly Drinker
6.480200E-01
Normal-vs-Occasional Drinker
2.393000E-01
Normal-vs-Social Drinker
4.482400E-01
Non Drinker-vs-Daily Drinker
8.604600E-01
Non Drinker-vs-Weekly Drinker
9.438800E-01
Non Drinker-vs-Occasional Drinker
3.009200E-01
Non Drinker-vs-Social Drinker
7.609200E-01
Daily Drinker-vs-Weekly Drinker
9.406400E-01
Daily Drinker-vs-Occasional Drinker
2.727400E-01
Daily Drinker-vs-Social Drinker
4.847000E-01
Weekly Drinker-vs-Occasional Drinker
3.823600E-01
Weekly Drinker-vs-Social Drinker
7.242000E-01
Occasional Drinker-vs-Social Drinker
7.517600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.049400E-01
Normal-vs-Grade 2
7.091200E-01
Normal-vs-Grade 3
7.309800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.68764999999294E-05
Grade 1-vs-Grade 3
1.023060E-03
Grade 1-vs-Grade 4
6.049400E-01
Grade 2-vs-Grade 3
5.536400E-01
Grade 2-vs-Grade 4
7.091200E-01
Grade 3-vs-Grade 4
7.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.191800E-01
Normal-vs-NonDiabetic
5.049400E-01
Diabetic-vs-NonDiabetic
6.211600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.071040E-01
Normal-vs-NoPancreatitis
5.819400E-01
Pancreatitis-vs-NoPancreatitis
1.440410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.236400E-01
Normal-vs-N1
5.272400E-01
N0-vs-N1
7.694600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.432800E-01
Normal-vs-TP53-NonMutant
7.163400E-01
TP53-Mutant-vs-TP53-NonMutant
3.572600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
